LMWE:F:F-Lyxor FTSE EPRA/NAREIT Global Developed UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 42.85

Change

-0.29 (-0.66)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.18 (-0.65%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.34 (-0.66%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.22 (-0.22%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.32 (-0.57%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.95 (-0.40%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.64%)

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.09 (-0.09%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.23%)

USD 40.74B
0ZC:F Zscaler Inc

+5.22 (+3.51%)

USD 37.92B

ETFs Containing LMWE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.31% 48% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.31% 44% F 50% F
Trailing 12 Months  
Capital Gain 19.96% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.96% 58% F 55% F
Trailing 5 Years  
Capital Gain -12.02% 15% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.02% 15% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain 0.01% N/A N/A 45% F
Dividend Return 0.01% N/A N/A 39% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.07% N/A N/A 69% C-
Risk Adjusted Return 0.04% N/A N/A 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike